Medicament for treating prostatic disease

Abstract

The invention relates to a medicament for treating a prostatic disease, which is prepared from the following Chinese medical herbs in parts by weight: 40-60 parts of rehmanniae praeparatum, 40-60 parts of rehmanniae vaporata, 50-70 parts of common macrocarpium fruit, 40-60 parts of epimedium, 40-60 parts of morindae, 40-60 parts of desertliving cistanche, 40-60 parts of south dodder seed, 40-60 parts of malaytea scurfpea fruit, 40-60 parts of common cnidium fruit, 40-60 parts of palmleaf raspberry fruit, 30-50 parts of Chinese magnoliavine fruit, 20-40 parts of cassia bark, 30-50 parts of fennel fruit, 30-50 parts of cervus nippon temminck, 30-50 parts of eucommia bark, 30-50 parts of achyranthes root, 30-50 parts of Indian buead, 30-50 parts of dioscoreae, 30-50 parts of Chinese eaglewood, 40-60 parts of dendrobium, 40-60 parts of scrophularia, 30-50 parts of cluster mallow fruit, 40-60 parts of herba pyrrosiae, 40-60 parts of plantago seed, 40-60 parts of rhizoma anemarrhenae, 40-60parts of phellodendron, 40-60 parts of white paeony root and 30-50 parts of raw liquorice root, and capsules are prepared by the steps of grinding the Chinese medical herbs into fine powder and encapsuling. The medicament has effects of invigorating yin, supporting yang, resuscitating and treating stranguria and is mainly suitable for chronic prostatitis or prostatic hyperplasia.

Description

technical field [0001] The invention relates to a medicament for treating prostate diseases, in particular to a medicament for treating prostate diseases prepared by taking traditional Chinese medicines as raw materials. Background technique [0002] Prostate disease is a common and frequently-occurring disease among middle-aged and elderly men, which seriously plagues the physical and mental health of middle-aged and elderly men. So far, there is still no simple and effective treatment for this disease, which is one of the difficult problems faced by modern medicine. This disease is caused by the infection of pathogenic bacteria to the prostate through blood and lymph, or the infection and spread of other parts of the genitourinary system. , chlamydia infection, mixed infection is also common in clinical practice, therefore, it is difficult to detect pathogenic microorganisms, targeted treatment drugs, in addition, the barrier function of the acinar epithelial lipid membran...

AI Technical Summary

Problems solved by technology

This disease is caused by the infection of pathogenic bacteria to the prostate through blood and lymph, or the infection and spread of other parts of the genitourinary system. , chlamydia infection, mixed infection is also common in clinical practice, therefore, it is difficult to detect pathogenic microorganisms, targeted treatment drugs, in addition, the barrier function of the acinar epithelial lipid membrane of the prostate gland makes it difficult for antibiotics to penetrate into the gland In vivo, so the treatment effect is often unsatisfactory. The current treatment measures are mainly the application of antibacterial drugs, physical therapy, hot water sitz bath, prostate massage, etc. have no certain curative effect

Images